01
Product access & distribution
Specialty distribution, rare and orphan pharmacy, long-term care, compounding, sampling, reverse logistics and alternative sourcing.
Managing Partner
Matthew Johnson
Operator. Strategist. Board member. Investor advisor. Executive coach.
Matthew works with private equity firms, boards and C-suite leaders where commercial performance and leadership cannot be separated.
Across more than 25 years in strategy, M&A, healthcare commercialization and executive leadership, he has learned to see the full system: the asset, the operating model, the board agenda and the people accountable for delivering the result.
At a glance
Full P&L leadership
Healthcare strategy & M&A
PE & investor advisory
Board & CEO partnership
Executive coaching
Specialty pharma commercialization
About Matthew
An executive who followed the problem all the way through
Strategy showed him where value could be created. Operating leadership showed him what it took to create it.
Matthew began his career as an engineer, moved into international business development, and then into corporate strategy and M&A. At AmerisourceBergen Specialty Group, his work sat at the intersection of transactions and strategy work in the style of an operating partner.
He later stepped into full operating responsibility for ASD Healthcare—leading sales, finance, procurement, marketing, operations, provider solutions and customer service. That transition changed how he understood performance.
A sound strategy can still fail through execution, capital discipline, organizational behavior or leadership. Commercial problems often become people problems, and people problems ultimately show up in commercial results.
How Matthew works
Analytical, direct and deeply human.
He isolates the material factors, tests assumptions and moves fluidly between market dynamics, finance, board expectations and the leadership system responsible for execution.
Healthcare, life sciences & pharma
Deep sector expertise, built from inside the system
Matthew has worked across complex therapies as a strategist, acquirer, operator, director, advisor and coach—connecting commercial strategy to the delivery systems that make access possible.
02
Patient & provider services
Infusion, home infusion, hub and patient services, physician-practice support, oncology services and direct-to-consumer models.
03
Therapies & strategy
Rare and orphan disease, oncology, cell and gene therapy, biosimilars, launches, manufacturer and payer strategy, and health economics.
04
Logistics & technology
Clinical-trial logistics, cold-chain transport, specialty shipping, healthcare data and technologies supporting commercialization.
Especially relevant when
A PE firm is evaluating a healthcare asset
A founder-led business is scaling under institutional ownership
A leadership team must translate a value-creation plan into action
A manufacturer is preparing for launch or commercialization
Strategy, M&A & value creation
A transaction should add a capability—not merely more revenue
As Head of Strategy and M&A for AmerisourceBergen Specialty Group, Matthew helped shape strategic rationale, investment approval, transaction execution, integration and portfolio direction during a period of significant growth.
01 / Diagnose
Understand how value is actually created
Economics, customers, capabilities, constraints and the few assumptions carrying the plan.
02 / Decide
Choose the right strategic move
Invest, acquire, build, partner, repair, sell or close—with explicit trade-offs and decision criteria.
03 / Deliver
Translate intent into operating reality
Integration, accountability, capital discipline and leadership alignment around the value-creation agenda.
The questions that matter
How does the business really make money?
Which capabilities do customers value most?
What is limiting performance today?
Which growth paths are truly achievable?
Operating leadership
From advisor to accountable operator
When Matthew took responsibility for ASD Healthcare, the mandate began with stabilization: restore discipline, strengthen critical relationships and refocus the business on the areas where it could create the most value.
Boards, PE & portfolio companies
Useful in the boardroom because he has carried the accountability outside it
Matthew has reported to boards, served as a director and advisor, partnered with sponsors and founders, and coached the CEOs responsible for delivering the plan.
Strategy & value creation
Clarifying the value thesis, challenging assumptions and keeping attention on the decisions that matter most.
CEO & team support
Helping leaders navigate first-time institutional ownership, changing expectations and high-consequence talent choices.
Governance & alignment
Strengthening the relationship among founders, sponsors and management while improving how the board creates value.
M&A & integration
Connecting deal logic with operating realities, leadership capacity and the practical work of integration.
Board & advisory roles
Current board and advisory roles
Matthew’s board and advisory work is concentrated in healthcare, life sciences and the operating systems that support them.
Partner
AkuraTemp
Temperature-security solutions for healthcare and life sciences logistics.
Visit organization Lead Independent DirectorPRO-Spectus
Patient services and access support for life sciences organizations.
Visit organization Board MemberAccess Infusion Care
Expanding infusion care for patients in rural and underserved communities.
Visit organization Board MemberThermal Shipping Solutions
Cold-chain packaging and validation for temperature-sensitive products.
Visit organization Board MemberAllyGPO
A community-focused specialty GPO serving independent oncology and ophthalmology practices.
Visit organization Board MemberBioCareSD
Specialty distribution and 3PL support for rare, orphan and other complex therapies.
Visit organizationPast deals
Selected realized investments and exits
Previous board and advisory work where Matthew helped organizations navigate growth, value creation and successful transactions.
PANTHERx Rare Pharmacy
Rare and orphan pharmacy acquired in October 2026.
NovoLogix
Specialty-drug medical-benefit technology platform acquired by CVS/Caremark.
Selected updates
From the work and the boardroom
Leadership in practice at PRO-Spectus
A short look inside Matthew’s work as Lead Independent Director.
View the updatePANTHERx Rare enters its next chapter
A Warburg Pincus-led investor group has agreed to acquire a controlling interest in the rare-disease pharmacy platform.
Read the updateExecutive coaching & assessment
The hardest business problems often become people problems
Matthew coaches CEOs and C-suite leaders in private equity–backed and public-company environments. His operating background allows him to understand the commercial stakes without taking ownership away from the executive.
The work starts from coaching. Where useful—and explicitly agreed—he can bring an operator’s perspective to the decisions underneath the development agenda.
Where the work is most useful
A founder becoming a private equity–backed CEO
A first-time CEO stepping into broader accountability
A leader succeeding a founder
A senior team navigating performance or talent decisions
A strong executive moving from good to exceptional
Experience
A career built across the full value-creation arc
Engineering discipline, transaction strategy, operating leadership, board service and executive development inform one integrated point of view.
2019–Present
Ingenium Global
Managing Partner (Healthcare, Life Sciences & Pharmaceutical Commercialization)
2012–2019
AmerisourceBergen
COO & General Manager, ASD Healthcare; later SVP, Pricing & Business Development
2003–2012
AmerisourceBergen Specialty Group
Vice President, Strategy & M&A
1995–2003
Global strategy & business development
Leadership roles at Underwriters Laboratories, ASI Group and HLMT Mikrosystem
Work with Matthew
Begin with the decision—not the service category
Whether you are evaluating a healthcare investment, supporting a portfolio CEO, building a more useful board or navigating a high-stakes senior role, start with what is happening, who is involved and what remains uncertain.
From there, Matthew can help determine the right mix of advisory, board, coaching or assessment support.
Begin a conversation